Efficacy and tolerability of oxycodone hydrochloride controlled-release tablets in moderate to severe cancer pain

Clinical Drug Investigation

Volumn 27, Issue 4, 2007, Pages 259-267

  Pan, Hongming ^a   Zhang, Zaiyun ^a   Zhang, Yiping ^b   Xu, Nong ^c   Lu, Liqin ^d   Dou, Chunfeng ^e   Guo, Yong ^f   Wu, Shixiu ^g   Yue, Jianhua ^h   Wu, Dongping ⁱ   Dai, Yuechu ^j  

^a ZHEJIANG UNIVERSITY   (China)

^b ZHEJIANG CANCER HOSPITAL   (China)

^c ZHEJIANG UNIVERSITY SCHOOL OF MEDICINE   (China)

^d ZHEJIANG PROVINCIAL PEOPLE'S HOSPITAL   (China)

^e ZHEJIANG HOSPITAL   (China)

^f Department of Anesthesiology   (China)

^g WENZHOU MEDICAL UNIVERSITY   (China)

^h Armed Police Hospital of Hangzhou   (China)

ⁱ People s Hospital of Shaoxing City   (China)

^j Central Hospital of Taizhou City   (China)

more..

Author keywords

[No Author keywords available]

Indexed keywords

INDOMETACIN; MORPHINE; OXYCODONE; PARACETAMOL;

ABDOMINAL DISTENSION; ABDOMINAL PAIN; ACUTE ABDOMEN; ADULT; AGED; ANALGESIC ACTIVITY; APPETITE; ARTICLE; CANCER PAIN; CLINICAL TRIAL; CONSCIOUSNESS; CONSTIPATION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DAILY LIFE ACTIVITY; DISEASE SEVERITY; DIZZINESS; DOSE RESPONSE; DROWSINESS; DRUG DOSE REDUCTION; DRUG DOSE TITRATION; DRUG EFFICACY; DRUG SAFETY; DRUG SUBSTITUTION; DRUG TOLERABILITY; DRUG WITHDRAWAL; DYSURIA; FEMALE; FOLLOW UP; GASTROINTESTINAL OBSTRUCTION; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; NAUSEA; PAIN ASSESSMENT; PRIORITY JOURNAL; SCORING SYSTEM; SIDE EFFECT; SUSTAINED DRUG RELEASE; TABLET FORMULATION; URINE RETENTION; VOMITING;

ADULT; AGED; AGED, 80 AND OVER; ANALGESICS, OPIOID; DELAYED-ACTION PREPARATIONS; FEMALE; HUMANS; MALE; MIDDLE AGED; OXYCODONE; PAIN; SEVERITY OF ILLNESS INDEX;

EID: 33947327851     PISSN: 11732563     EISSN: None     Source Type: Journal    
DOI: 10.2165/00044011-200727040-00005     Document Type: Article

References (37)

1. Zhukovsky DS, Abdullah O, Richardson M, et al. Clinical evaluation in advanced cancer. Semin Oncol 2000; 27 (1): 14-23
2. Cherny N. The management of cancer pain. Cancer J Clin 2000; 50: 70-116
3. Hearn J, Higginson IJ. Cancer pain epidemiology: a systematic review. In: Bruera ED, Portenoy RK, editors. Cancer pain, assessment and management. Cambridge: Cambridge University Press, 2003
4. Abrahm JL. Promoting symptom control in palliative care. Semin Oncol Nurs 1998; 14 (2): 95-109
5. Mercadante S, Fulfaro F. World Health Organization guidelines for cancer pain: a reappraisal. Ann Oncol 2005; 16 Suppl. 4: iv132-5
6. Wootton M. Morphine is not the only analgesic in palliative care: literature review. J Adv Nurs 2004; 45: 527-32
7. McNicol E, Strassels S, Goudas L, et al. Nonsteroidal anti-inflammatory drugs, alone or combined with opioids, for cancer pain: a systematic review. J Clin Oncol 2004; 22: 1975-92
8. Stambaugh JE, Reder RF, Stambaugh MD, et al. Double-blind, randomized comparison of the analgesic and pharmacokinetic profiles of controlled- and immediate-release oral oxycodone in cancer pain patients. J Clin Pharmacol 2001; 41 (5): 500-6
9. Kaplan R, Parris WCV, Citron ML, et al. Comparison of controlled-release and immediate-release oxycodone tablets in patients with cancer pain. J Clin Oncol 1998; 16 (10): 3230-7
10. Koizumi W, Toma H, Watanabe K, et al. Efficacy and tolerability of cancer pain management with controlled-release oxycodone tablets in opioid-naive cancer pain patients, starting with 5mg tablets. Jpn J Clin Oncol 2004; 34 (10): 608-14
11. Parris WC, Johnson Jr BW, Croghan MK, et al. The use of controlled-release oxycodone for the treatment of chronic cancer pain: a randomized, double-blind study. J Pain Symptom Manage 1998; 16 (4): 205-11
12. Hagen NA, Babul N. Comparative clinical efficacy and safety of a novel controlled-release oxycodone formulation and controlled-release hydromorphone in the treatment of cancer pain. Cancer 1997; 79 (7): 1428-37
13. Markenson JA, Croft J, Zhang PG, et al. Treatment of persistent pain associated with osteoarthritis with controlled-release oxycodone tablets in a randomized controlled clinical trial. Clin J Pain 2005; 21 (6): 524-35
14. Nicholson B, Ross E, Sasaki J, et al. Randomized trial comparing polymer-coated extended-release morphine sulfate to controlled-release oxycodone HCl in moderate to severe nonmalignant pain. Curr Med Res Opin 2006; 22 (8): 1503-14
15. Zautra AJ, Smith BW. Impact of controlled-release oxycodone on efficacy beliefs and coping efforts among osteoarthritis patients with moderate to severe pain. Clin J Pain 2005; 21 (6): 471-7
16. Hale ME, Fleischmann R, Salzman R, et al. Efficacy and safety of controlled-release versus immediate-release oxycodone: randomized, double-blind evaluation in patients with chronic back pain. Clin J Pain 1999; 15 (3): 179-83
17. Cheville A, Chen A, Oster G, et al. A randomized trial of controlled-release oxycodone during inpatient rehabilitation following unilateral total knee arthroplasty. J Bone Joint Surg Am 2001; 83-A (4): 572-6
18. Gammaitoni AR, Galer BS, Bulloch S, et al. Randomized, double-blind, placebo-controlled comparison of the analgesic efficacy of oxycodone 10mg/acetaminophen 325mg versus controlled-release oxycodone 20mg in postsurgical pain. J Clin Pharmacol 2003; 43 (3): 296-304
19. de Beer Jde V, Winemaker MJ, Donnelly GA, et al. Efficacy and safety of controlled-release oxycodone and standard therapies for postoperative pain after knee or hip replacement. Can J Surg 2005; 48 (4): 277-83
20. Czarnecki ML, Jandrisevits MD, Theiler SC, et al. Controlled-release oxycodone for the management of pediatric postoperative pain. J Pain Symptom Manage 2004; 27 (4): 379-86
21. National Comprehensive Cancer Network (NCCN). Adult Cancer Pain, Clinical Practice Guidelines in Oncology, 2005; vol. 2 [online]. Available from URL: http:www.nccn.org/professionals/physician_gls/PDF/pain.pdf [Accessed 2005 Aug 3]
22. Li Jinxiang, Robert GT, Mellar PD. Palliative medicine.1st ed. Beijing: People's Health Press, 2005
23. Cohen MZ, Easley MK, Ellis C, et al. Cancer pain management and the JCAHO's pain standards: an institutional challenge. J Pain Symptom Manage 2003; 25: 519-27
24. Kalso E. Oxycodone. J Pain Symptom Manage 2005; 29 (5 Suppl.): S47-56
25. Mucci-LoRusso P, Berman BS, Silberstein PT, et al. Controlled-release oxycodone compared with controlled-release morphine in the treatment of cancer pain: a randomized, double-blind, parallel-group study. Eur J Pain 1998; 2 (3): 239-49
26. Curtis GB, Johnson GH, Clark P, et al. Relative potency of controlled-release oxycodone and controlled-release morphine in a postoperative pain model. Eur J Clin Pharmacol 1999; 55 (6): 425-9
27. Hanks GW, Conno F, Cherny N, et al. Morphine and alternative opioids in cancer pain: the EAPC recommendations. Br J Cancer 2001; 84 (5): 587-93
28. Poyhia R, Vainio A, Kalso E. A review of oxycodone's clinical pharmacokinetics and pharmacodynamics. J Pain Symptom Manage 1993; 8 (2): 63-7
29. Coluzzi F, Mattia C. Oxycodone: pharmacological profile and clinical data in chronic pain management. Minerva Anestesiol 2005; 71 (7-8): 451-60
30. Gammaitoni AR, Galer BS, Lacouture P, et al. Effectiveness and safety of new oxycodone/acetaminophen formulations with reduced acetaminophen for the treatment of low back pain. Pain Med 2003; 4 (1): 21-30
31. Levy MH. Advancement of opioid analgesia with controlled-release oxycodone. Eur J Pain 2001; 5 Suppl. A: 113-6
32. Lauretti GR, Oliveira GM, Pereira NL. Comparison of sustained-release morphine with sustained-release oxycodone in advanced cancer patients. Br J Cancer 2003; 9 (11): 2027-30
33. Kaiko RF, Benziger DP, Fitzmartin RD, et al. Pharmacokinetic- pharmacodynamic relationships of controlled-release oxycodone. Clin Pharmacol Ther 1996; 59 (1): 52-61
34. Sunshine A, Olson NZ, Colon A, et al. Analgesic efficacy of controlled-release oxycodone in postoperative pain. J Clin Pharmacol 1996; 36 (7): 595-603
35. Gabrail NY, Dvergsten C, Ahdieh H. Establishing the dosage equivalency of oxymorphone extended release and oxycodone controlled release in patients with cancer pain: a randomized controlled study. Curr Med Res Opin 2004; 20 (6): 911-8
36. Hanks GW, Twycross RG, Bliss JM. Controlled-release morphine tablets: a double-blind trial in patients with advanced cancer. Anaesthesia 1987; 42 (8): 840-4
37. Heiskanen TE, Ruismaki PM, Seppala TA, et al. Morphine or oxycodone in cancer pain? Acta Oncol 2000; 39 (8): 941-7